TY - JOUR
T1 - PI3Kγ inhibition circumvents inflammation and vascular leak in SARS-CoV-2 and other infections
AU - Shepard, Ryan M.
AU - Ghebremedhin, Anghesom
AU - Pratumchai, Isaraphorn
AU - Robinson, Sally R.
AU - Betts, Courtney
AU - Hu, Jingjing
AU - Sasik, Roman
AU - Fisch, Kathleen M.
AU - Zak, Jaroslav
AU - Chen, Hui
AU - Paradise, Marc
AU - Rivera, Jason
AU - Amjad, Mohammad
AU - Uchiyama, Satoshi
AU - Seo, Hideya
AU - Campos, Alejandro D.
AU - Dayao, Denise Ann
AU - Tzipori, Saul
AU - Piedra-Mora, Cesar
AU - Das, Soumita
AU - Hasteh, Farnaz
AU - Russo, Hana
AU - Sun, Xin
AU - Xu, Le
AU - Alexander, Laura Crotty E.
AU - Duran, Jason M.
AU - Odish, Mazen
AU - Pretorius, Victor
AU - Kirchberger, Nell C.
AU - Chin, Shao Ming
AU - Schalscha, Tami Von
AU - Cheresh, David
AU - Morrey, John D.
AU - Alargova, Rossitza
AU - O’Connell, Brenda
AU - Martinot, Theodore A.
AU - Patel, Sandip P.
AU - Nizet, Victor
AU - Martinot, Amanda J.
AU - Coussens, Lisa M.
AU - Teijaro, John R.
AU - Varner, Judith A.
N1 - Publisher Copyright:
© 2024 American Association for the Advancement of Science. All rights reserved.
PY - 2024
Y1 - 2024
N2 - Virulent infectious agents such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and methicillin-resistant Staphylococcus aureus (MRSA) induce tissue damage that recruits neutrophils, monocyte, and macrophages, leading to T cell exhaustion, fibrosis, vascular leak, epithelial cell depletion, and fatal organ damage. Neutrophils, monocytes, and macrophages recruited to pathogen-infected lungs, including SARS-CoV-2–infected lungs, express phosphatidylinositol 3-kinase gamma (PI3Kγ), a signaling protein that coordinates both granulocyte and monocyte trafficking to diseased tissues and immune-suppressive, profibrotic transcription in myeloid cells. PI3Kγ deletion and inhibition with the clinical PI3Kγ inhibitor eganelisib promoted survival in models of infectious diseases, including SARS-CoV-2 and MRSA, by suppressing inflammation, vascular leak, organ damage, and cytokine storm. These results demonstrate essential roles for PI3Kγ in inflammatory lung disease and support the potential use of PI3Kγ inhibitors to suppress inflammation in severe infectious diseases.
AB - Virulent infectious agents such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and methicillin-resistant Staphylococcus aureus (MRSA) induce tissue damage that recruits neutrophils, monocyte, and macrophages, leading to T cell exhaustion, fibrosis, vascular leak, epithelial cell depletion, and fatal organ damage. Neutrophils, monocytes, and macrophages recruited to pathogen-infected lungs, including SARS-CoV-2–infected lungs, express phosphatidylinositol 3-kinase gamma (PI3Kγ), a signaling protein that coordinates both granulocyte and monocyte trafficking to diseased tissues and immune-suppressive, profibrotic transcription in myeloid cells. PI3Kγ deletion and inhibition with the clinical PI3Kγ inhibitor eganelisib promoted survival in models of infectious diseases, including SARS-CoV-2 and MRSA, by suppressing inflammation, vascular leak, organ damage, and cytokine storm. These results demonstrate essential roles for PI3Kγ in inflammatory lung disease and support the potential use of PI3Kγ inhibitors to suppress inflammation in severe infectious diseases.
UR - http://www.scopus.com/inward/record.url?scp=85197724666&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85197724666&partnerID=8YFLogxK
U2 - 10.1126/scitranslmed.adi6887
DO - 10.1126/scitranslmed.adi6887
M3 - Article
C2 - 38959328
AN - SCOPUS:85197724666
SN - 1946-6234
VL - 16
JO - Science translational medicine
JF - Science translational medicine
IS - 754
M1 - adi6887
ER -